Zenas Biopharma Inc (ZBIO)

Dec 17, 2024

Zenas BioPharma initiated with a Buy at H.C. Wainwright - Yahoo Finance

Dec 17, 2024

Dec 16, 2024

HC Wainwright & Co. Initiates Coverage of Zenas BioPharma (ZBIO) with Buy Recommendation - MSN

Dec 16, 2024

Dec 16, 2024

This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Dec 16, 2024

Dec 16, 2024

H.C. Wainwright starts Zenas stock with Buy rating, eyes Obexelimab’s role in autoimmune treatment - Investing.com Australia

Dec 16, 2024

Dec 13, 2024

Guggenheim maintains buy on ZBIO shares, sees strong drug potential By Investing.com - Investing.com Canada

Dec 13, 2024

Dec 12, 2024

Zenas BioPharma price target lowered to $35 from $40 at Morgan Stanley - Yahoo Finance

Dec 12, 2024

Dec 04, 2024

Zenas BioPharma CEO Leon O. Moulder Jr. purchases $718,100 in stock - Investing.com

Dec 04, 2024

Nov 21, 2024

Zenas BioPharma CEO Leon O. Moulder Jr. acquires shares worth $148,925 - Investing.com Australia

Nov 21, 2024

Nov 21, 2024

Zenas BioPharma CEO Leon O. Moulder Jr. acquires shares worth $148,925 By Investing.com - Investing.com South Africa

Nov 21, 2024

Nov 14, 2024

Zenas BioPharma Inc. (ZBIO) Quarterly 10-Q Report - Quartz

Nov 14, 2024

Nov 13, 2024

FMR LLC Acquires New Stake in Zenas BioPharma Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Zenas BioPharma Raises $259M in IPO, Advances Phase 3 Trial Amid Growing R&D Investment | ZBIO Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Zenas BioPharma Completes Targeted Enrollment of the Phase - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Zenas BioPharma Hits Milestone: Completes Enrollment in Largest-Ever IgG4-RD Trial | ZBIO Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Zenas BioPharma To Attend Upcoming Healthcare Investor Conferences - BERNAMA

Nov 08, 2024

Nov 07, 2024

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences - BERNAMA

Nov 07, 2024

Nov 07, 2024

TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Arm Holdings Plc ADR (ARM-Q) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Nov 07, 2024

Oct 22, 2024

Zenas Bio: Recent IPO With Late-Stage Candidate (NASDAQ:ZBIO) - Seeking Alpha

Oct 22, 2024

Oct 08, 2024

Zenas started at buy by four banks on lead drug potential (NASDAQ:ZBIO) - Seeking Alpha

Oct 08, 2024

Oct 08, 2024

Zenas stock backed by Guggenheim on strong outlook for lead drug obexelimab - Investing.com Canada

Oct 08, 2024

Oct 08, 2024

Morgan Stanley bullish on Zenas Biopharma stock as obexelimab trials gain momentum - Investing.com Canada

Oct 08, 2024

Oct 08, 2024

Citi sees upside in Zenas Biopharma stock as obexelimab progresses in key trials - Investing.com Canada

Oct 08, 2024

Oct 08, 2024

Jefferies bullish on Zenas stock as obexelimab advances in autoimmune trials - Investing.com Canada

Oct 08, 2024

Oct 04, 2024

Biopharma financings surge to $86.2B in 2024, with $8.7B in September - BioWorld Online

Oct 04, 2024

Oct 01, 2024

Halda appoints new chief executive - The Pharma Letter

Oct 01, 2024

Sep 27, 2024

IgG4-related Disease Market to Show Remarkable Growth Trends - openPR

Sep 27, 2024

Sep 22, 2024

Last Week's 3 Biotech IPOs Prompt Huge Insider Buying - 24/7 Wall St.

Sep 22, 2024

Sep 21, 2024

Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN

Sep 21, 2024

Sep 21, 2024

Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com India

Sep 21, 2024

Sep 20, 2024

Zenas BioPharma CEO acquires $360k worth of company shares By Investing.com - Investing.com South Africa

Sep 20, 2024

Sep 20, 2024

Zenas BioPharma’s $225 Million IPO - Global Legal Chronicle

Sep 20, 2024

Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering - The Korea Bizwire

Sep 19, 2024

Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase ... - The Bakersfield Californian

Sep 19, 2024

Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of - GlobeNewswire

Sep 19, 2024

Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in - EIN News

Sep 19, 2024

Sep 19, 2024

Upstream Bio goes public amid spate of IPOs - The Pharma Letter

Sep 19, 2024

Sep 18, 2024

Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com South Africa

Sep 18, 2024

Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com South Africa

Sep 17, 2024

Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock - Investing.com Canada

Sep 17, 2024